Your browser doesn't support javascript.
loading
Disulfiram Transcends ALDH Inhibitory Activity When Targeting Ovarian Cancer Tumor-Initiating Cells.
Caminear, Michael W; Harrington, Brittney S; Kamdar, Rahul D; Kruhlak, Michael J; Annunziata, Christina M.
Afiliación
  • Caminear MW; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
  • Harrington BS; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
  • Kamdar RD; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
  • Kruhlak MJ; Center for Cancer Research (CCR) Confocal Microscopy Core Facility, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute (NIH), Bethesda, MD, United States.
  • Annunziata CM; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Front Oncol ; 12: 762820, 2022.
Article en En | MEDLINE | ID: mdl-35372040

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos